Division of Cardiology, Department of Medicine, Heart Rhythm Center, Taipei Veterans General Hospital, Taipei, Taiwan.
Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
J Cardiovasc Electrophysiol. 2020 Jun;31(6):1436-1447. doi: 10.1111/jce.14457. Epub 2020 Apr 6.
Accurate identification of slow conducting regions in patients with scar-related atrial tachycardia (AT) is difficult using conventional electrogram annotation for cardiac electroanatomic mapping (EAM). Estimating delays between neighboring mapping sites is a potential option for activation map computation. We describe our initial experience with CARTO 3 Coherent Mapping (Biosense Webster Inc,) in the ablation of complex ATs.
Twenty patients (58 ± 10 y/o, 15 males) with complex ATs were included. We created three-dimensional EAMs using CARTO 3 system with CONFIDENSE and a high-resolution mapping catheter (Biosense Webster Inc). Local activation time and coherent maps were used to aid in the identification of conduction isthmus (CI) and focal origin sites. System-defined slow or nonconducting zones and CI, defined by concealed entrainment (postpacing interval < 20 ms), CV < 0.3 m/s and local fractionated electrograms were evaluated.
Twenty-six complex ATs were mapped (mean: 1.3 ± 0.7 maps/pt; 4 focal, 22 isthmus-dependent). Coherent mapping was better in identifying CI/breakout sites where ablation terminated the tachycardia (96.2% vs 69.2%; P = .010) and identified significantly more CI (mean/chamber 2.0 ± 1.1 vs 1.0 ± 0.7; P < .001) with narrower width (19.8 ± 10.5 vs 43.0 ± 23.9 mm; P < .001) than conventional mapping. Ablation at origin and CI sites was successful in 25 (96.2%) with long-term recurrence in 25%.
Coherent mapping with conduction velocity vectors derived from adjacent mapping sites significantly improved the identification of CI sites in scar-related ATs with isthmus-dependent re-entry better than conventional mapping. It may be used in conjunction with conventional mapping strategies to facilitate recognition of slow conduction areas and critical sites that are important targets of ablation.
在使用心脏电生理标测(EAM)的常规电信号标注识别与瘢痕相关的房性心动过速(AT)的慢传导区域时,准确性较差。估计相邻标测部位之间的延迟是计算激活图的潜在选择。我们描述了我们在使用 CARTO 3 相干映射(Biosense Webster Inc.)消融复杂 AT 方面的初步经验。
共纳入 20 例(58±10 岁,15 例男性)复杂 AT 患者。我们使用 CARTO 3 系统和 CONFIDENSE 以及高分辨率标测导管(Biosense Webster Inc.)创建了三维 EAM。使用局部激活时间和相干图来帮助识别传导峡部(CI)和局灶起源部位。评估系统定义的慢区或无传导区和由隐匿性拖带(起搏后间期<20ms)、CV<0.3m/s 和局部碎裂电图定义的 CI。
共标测 26 例复杂 AT(平均 1.3±0.7 个/例;4 例局灶性,22 例峡部依赖性)。相干图在识别消融终止心动过速的 CI/突破部位(96.2%比 69.2%;P=0.010)和识别更多 CI 方面表现更好(平均/腔室 2.0±1.1 比 1.0±0.7;P<0.001),CI 宽度更窄(19.8±10.5 比 43.0±23.9mm;P<0.001)。起源和 CI 部位的消融在 25 例(96.2%)中成功,25 例长期复发。
与传统标测相比,基于相邻标测部位传导速度矢量的相干图显著提高了对与瘢痕相关的、具有峡部依赖性折返的 AT 中 CI 部位的识别能力。它可以与传统的标测策略结合使用,以帮助识别慢传导区域和重要的消融靶点。